CeriBell, Inc.

CBLL ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023
Operating Activities
Net Income $-53.4M $-40.5M $-29.5M
Depreciation & Amortization $1.3M $1.1M $847.0K
Depreciation $300.0K $400.0K $300.0K
Amortization — — —
Stock-Based Compensation $12.2M $5.4M $2.7M
Net Cash from Operating Activities $-40.8M $-35.0M $-29.2M
Investing Activities
Capital Expenditures $767.0K $1.3M $983.0K
Business Acquisitions — — —
Net Cash from Investing Activities $-118.1M $-1.6M $-1.8M
Financing Activities
Dividends Paid — — —
Stock Repurchases — — —
Net Cash from Financing Activities $5.1M $196.5M $-2.8M
Net Change in Cash $-153.9M $159.9M $-33.7M
Free Cash Flow $-41.6M $-36.4M $-30.1M